Inactivation of osteoclasts and trabecular bone loss in the vertebrae and tibiae was observed in mice following systemic administration of OPG expressing MSCs, suggesting the protective effect of OPG in MM [73]. This evidence concerns the gene TNFRSF11B and Miyoshi myopathy.